That's good. Good management is key for investing in companies that are in the pennies. Mark is highly intelligent, seems to care about regular investors, and has a good, honest plan to build the company. I applaud him. And BTW, it won't take long with fins, FDA approval, and a national contract or two, to have a company valued easily at over $1.00/share, even with current share structure.